It has been widely observed that adult men of all ages are at higher risk of developing
serious complications from COVID-19 when compared with women. This study aimed to …

Objective —To determine whether hepatic portal vascularity, as assessed by intraoperative
mesenteric portovenography (IMP), is related to outcome in dogs undergoing attenuation of …

Background Data for front-line health-care workers and risk of COVID-19 are limited. We
sought to assess risk of COVID-19 among front-line health-care workers compared with the …

The composition of the gut microbiome has been associated with clinical responses to
immune checkpoint inhibitor (ICI) treatment, but there is limited consensus on the specific …

As no one symptom can predict disease severity or the need for dedicated medical support
in coronavirus disease 2019 (COVID-19), we asked whether documenting symptom time …

Background A clinically relevant, translational large animal model of acute liver failure ( ALF
) is required for testing of novel therapies to prolong survival in acute liver failure, to permit …

Individuals with cancer may be at high risk for coronavirus disease 2019 (COVID‐19) and
adverse outcomes. However, evidence from large population‐based studies examining …

Immune-checkpoint inhibitors (ICIs) have revolutionised the therapeutic landscape for
multiple malignancies and the health of the gut microbiome (GM) is strongly linked with …

Background Frailty, increased vulnerability to physiological stressors, is associated with
adverse outcomes. COVID-19 exhibits a more severe disease course in older, comorbid adults. …

Rev., Vol. 32, No. 2, pp. 64–68, 2004. Mechanical loading influences bone mass and
architecture through a cascade of cellular events that involve estrogen receptor α (ERα). An …